Skip to main content
SOPH logo

SOPHiA GENETICS SA

SOPHNASDAQHealthcareHealth Information Services

$7.05Today:- (-)1Y +71.12%

As of Oct 22, 2026 close

Market cap
$520.56M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.75$8.98
Volume (live)
-
Avg. volume (3M)
688.18K

SOPHiA GENETICS SA (SOPH) Income Statement

SOPHiA GENETICS SA reported revenue of $77.27M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 18.6% from $65.17M a year earlier. SOPHiA GENETICS SA posted a net loss of $79.00M, compared with a net loss of $62.49M a year earlier. Gross margin was 67.4% and operating margin -91.8%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $23.31M, up 27.2% from the same quarter a year earlier.

SOPHiA GENETICS SA Income Statement Analysis

Values in millions USD

Scroll to see more
SOPHiA GENETICS SA income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue77.2765.1762.3747.5640.4528.4025.36
Cost of Revenue25.1921.2419.4616.3115.2310.717.53
Gross Profit52.0843.9442.9131.2525.2217.6917.83
Operating Expenses
Research & Development34.2234.3736.9735.3726.5818.5915.02
Selling, General & Administrative86.0776.3281.7284.0870.2436.4035.08
Operating Expenses122.98110.51117.74119.0896.7155.0850.12
Operating Income-70.91-66.57-74.83-87.82-71.49-37.39-32.29
Other Income/Expense
Interest Income1.873.364.551.32-0.640.100.09
Interest Expense4.55-1.91-0.590.64-0.660.840.98
Other Income/Expense-3.905.30-3.670.24-2.02-3.84-1.34
Income
Income Before Tax-77.49-61.27-78.50-87.59-73.51-41.23-33.63
Income Tax Expense1.511.220.49-0.140.17-1.890.16
Net Income-79.00-62.49-78.98-87.45-73.68-39.34-33.79
Net Income - Continuous Operations-79.00-62.49-78.98-87.45-73.68-39.34-33.79
Net Income - Discontinued Operations-------
EBITDA-63.40-64.59-69.29-81.38-67.83-38.00-30.74
EBIT-72.93-66.57-74.80-87.75-71.44-37.16-
Depreciation & Amortization2.611.941.865.573.612.391.91
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-1.00-1.00-1.00
Diluted EPS-1.00-1.00-1.00-1.00-1.00-1.00-1.00
Basic Shares Outstanding67.5466.0664.7564.1055.3048.0263.86
Diluted Shares Outstanding67.5466.0664.7564.1055.3048.0263.86

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About SOPHiA GENETICS SA Financial Statements

What was SOPHiA GENETICS SA's revenue in fiscal 2025?

SOPHiA GENETICS SA reported revenue of $77.27M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 18.6% from $65.17M a year earlier.

Is SOPHiA GENETICS SA profitable?

No. SOPHiA GENETICS SA reported a net loss of $79.00M in fiscal 2025. In fiscal 2024 it lost $62.49M.

What is SOPHiA GENETICS SA's operating margin?

SOPHiA GENETICS SA's operating income was −$70.91M on revenue of $77.27M in fiscal 2025, an operating margin of -91.8%, compared with -102.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition